Daniel J Brackett
Overview
Explore the profile of Daniel J Brackett including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
51
Citations
1784
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Tompkins P, Tesiram Y, Lerner M, Gonzalez L, Lightfoot S, Rabb C, et al.
J Neurotrauma
. 2013 Jun;
30(22):1888-97.
PMID: 23777197
Blast wave-induced traumatic injury from terrorist explosive devices can occur at any time in either military or civilian environments. To date, little work has focused on the central nervous system...
12.
Qiu P, Qu X, Brackett D, Lerner M, Li D, Mao C
Adv Mater
. 2013 Mar;
25(17):2492-6.
PMID: 23450784
A novel scaffold composed of loosely branched hollow silica microfibers that has been proven to be highly biocompatible is proposed for the 3D culture of cancer cells. The MCF-7 cancer...
13.
Tesiram Y, Lerner M, Stewart C, Njoku C, Brackett D
Pancreas
. 2012 Mar;
41(3):474-80.
PMID: 22422139
Objectives: The aims of this study were (1) to determine nuclear magnetic resonance spectroscopic characteristics and metabolite profiles of serum samples from patients with pancreatic cancer compared with noncancerous control...
14.
Hocker J, Peyton M, Lerner M, Lightfoot S, Hanas R, Brackett D, et al.
Cancer Invest
. 2011 Dec;
30(2):180-8.
PMID: 22149138
Goals of this study were to analyze the ability of mass spectrometry serum profiling to distinguish non-small cell lung adenocarcinoma from squamous cell carcinoma patients and healthy controls. Sera were...
15.
Hocker J, Bishop E, Lightfoot S, Lerner M, Peyton M, Brackett D, et al.
Cancer Invest
. 2011 Dec;
30(2):189-97.
PMID: 22149058
Sera mass spectrometry (MS) peak differences were analyzed from 35 ovarian cancer patients and 16 disease-free individuals. "Leave one out" cross validation was used to assign "% cancer peaks" in...
16.
Hocker J, Peyton M, Lerner M, Mitchell S, Lightfoot S, Lander T, et al.
Lung Cancer
. 2011 May;
74(2):206-11.
PMID: 21529985
The goal of this study was to evaluate the usefulness of electrospray ionization-mass spectrometry (ESI-MS) technology to distinguish sera of early-stage lung cancer patients from control individuals. ESI-MS m/z (mass...
17.
Park J, Henry J, Jiang J, Esau C, Gusev Y, Lerner M, et al.
Biochem Biophys Res Commun
. 2011 Feb;
406(4):518-23.
PMID: 21329664
Numerous microRNAs (miRNAs) are reported as differentially expressed in cancer, however the consequence of miRNA deregulation in cancer is unknown for many miRNAs. We report that two miRNAs located on...
18.
Sureban S, May R, Lightfoot S, Hoskins A, Lerner M, Brackett D, et al.
Cancer Res
. 2011 Feb;
71(6):2328-38.
PMID: 21285251
Pancreatic cancer is an exceptionally aggressive disease in great need of more effective therapeutic options. Epithelial-mesenchymal transition (EMT) plays a key role in cancer invasion and metastasis, and there is...
19.
Hocker J, Lerner M, Mitchell S, Lightfoot S, Lander T, Quillet A, et al.
Cancer Invest
. 2011 Jan;
29(2):173-9.
PMID: 21261478
This study evaluated the usefulness of electrospray mass spectrometry to distinguish sera of early-stage pancreatic cancer patients from disease-free individuals. Sera peak data were generated from 33 pancreatic cancer patients...
20.
Mehta M, Kesinger J, Zang X, Lerner M, Brackett D, Brueggemeier R, et al.
Anticancer Res
. 2010 Dec;
30(12):4883-9.
PMID: 21187466
Background: Keratinocyte growth factor (KGF) acts at the KGF receptor (KGFR) to produce a rapid stimulation of breast cancer cell proliferation and motility which is mediated via the Erk signaling...